Arteriovenous Malformation clinical trials at UC Health
1 research study open to eligible people
Bevacizumab Therapy for Brain Arteriovenous Malformation
open to eligible people ages 18-64
Bevacizumab Therapy for brain arteriovenous malformation that is not amenable to surgical intervention.
at UCSF
Last updated: